Form 4 filed by PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. filed this Form 4 on QCLS (Q/C TECHNOLOGIES, INC.) with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-21 01:30:00 UTC.
- Accession
- 0001683168-26-009018
- Filer
- CIK 1157075
- Filed
- 2026-11-20
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: QCLS · Q/C TECHNOLOGIES, INC. (CIK 1321834)
- PharmaCyte Biotech, Inc. 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common stock | 2026-11-18 | X exercised | +4,982,272 | $0 | 5,152,000 | D |
| Series G Long-Term Warrants derivative | 2026-11-18 | X exercised | -851,304 | $0 | 13,318,344 | D |
| Series H Convertible Preferred Stock derivative | 2026-11-18 | J other | +3,000 | $0 | 3,000 | D |